Using global demand calibrations to evaluate policy: Case study of HIV pharmaceuticals

Consumers pay more for many pharmaceuticals in the US than in most other countries. This column investigates the welfare implications of such price discrimination using demand curves for HIV pharmaceuticals. A ban on price discrimination exacerbates the potentially large deadweight loss in the market for either a drug or a vaccine. However, this loss is ameliorated by a small government subsidy.

https://voxeu.org/article/using-global-demand-calibrations-evaluate-policy

Michael Kremer, Christopher Snyder, Fanele Mashwama

VOX

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *